Oriented Antibody Functionalized Plasmonic Yolk–Shell-Satellite Nanostructures for Ultrasensitive SERS-Based Lateral Flow Immunoassay
Analytical Chemistry · 05.08.2025 · 97 (30) · 16515-16524
DOI: 10.1021/acs.analchem.5c02561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 23.07.2025. Verfasst von Jiaojiao Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 21516…. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Metal Nanoparticles, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Conventional gold nanoparticle (AuNP)-based lateral flow immunoassays (LFIAs) for detecting matrix metalloproteinase-9 (MMP-9), a biomarker associated with dry eye disease and cancer, often suffer from limited sensitivity. To address this, we developed an ultrasensitive surface-enhanced Raman scattering (SERS)-based LFIA using plasmonic yolk-shell-satellite nanostructures (YSSNs) functionalized with bifunctional 4-mercaptophenylboronic acid (MPBA) as SERS tags. The YSSNs, composed of a gold nanorod core enclosed by a gold nanocage and decorated with satellite nanoparticles, provided strong SERS enhancement. MPBA not only acted as a robust Raman reporter but also improved the orientation of antibodies. The SERS-LFIA achieved a limit of detection of 0.0056 ng·mL-1 in PBS, a 305-fold improvement over conventional AuNP-LFIA, and demonstrated favorable linear detection in biological samples, with limits of 0.051 ng·mL-1 in serum and 0.030 ng·mL-1 in tears. This assay offers a sensitive and reliable platform for MMP-9 detection and has great potential for disease diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, P. R. China.
- Jinan Guoke Medical Technology Development Co., Ltd., Jinan 250101, P. R. China.
- University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
ORCID-Profile: Jiaojiao Sun, Jie Liu
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Science and Technology Program of Suzhou
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Chinese Academy of Sciences Key Laboratory of Bio-medical Diagnostics
Zitieren
APA
Sun, J., Li, L., Sun, R., Yin, H., & Liu, J. (2025). Oriented Antibody Functionalized Plasmonic Yolk–Shell-Satellite Nanostructures for Ultrasensitive SERS-Based Lateral Flow Immunoassay. Analytical Chemistry, 97(30), 16515-16524. https://doi.org/10.1021/acs.analchem.5c02561
Vancouver
Sun J, Li L, Sun R, Yin H, Liu J. Oriented Antibody Functionalized Plasmonic Yolk–Shell-Satellite Nanostructures for Ultrasensitive SERS-Based Lateral Flow Immunoassay. Analytical Chemistry. 2025;97(30):16515-16524. doi:10.1021/acs.analchem.5c02561
BibTeX
@article{Sun2025,
author = {Sun, Jiaojiao and Li, Lei and Sun, Rui and Yin, Huancai and Liu, Jie},
title = {Oriented Antibody Functionalized Plasmonic Yolk–Shell-Satellite Nanostructures for Ultrasensitive SERS-Based Lateral Flow Immunoassay},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {30},
pages = {16515--16524},
doi = {10.1021/acs.analchem.5c02561}
}
EUVIMED